HF
CTXR icon

HRT Financial’s Citius Pharmaceuticals CTXR Stock Holding History

HRT Financial’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54K Buy
+60,332
New +$48.7K ﹤0.01% 3443
2024
Q4 		– Sell
-1,487
Closed -$18K – 2550
2024
Q3 		$18K Sell
1,487
-2,517
-63% -$42.4K ﹤0.01% 2196
2024
Q2 		$58K Buy
+4,004
New +$71.7K ﹤0.01% 1817
2022
Q1 		– Sell
-3,635
Closed -$139K – 3231
2021
Q4 		$139K Buy
+3,635
New +$165K ﹤0.01% 2670

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's CTXR Position: Q1 2026 in Review

HRT Financial opened a new position in Citius Pharmaceuticals (CTXR) in Q1 2026: 60,332 shares worth $54K. The stake represents ﹤0.01% of the portfolio and ranks #3443 among its holdings. This is a return to the name: HRT Financial previously reported a position in CTXR as recently as Q3 2024.

HRT Financial first reported a position in CTXR in Q4 2021 and has held it in 4 quarters since. The position peaked at $139K in Q4 2021. 38 funds tracked by Wall St. Rank hold CTXR as of Q1 2026.

  • HRT Financial held 60,332 shares of Citius Pharmaceuticals worth $54K as of Q1 2026.
  • Citius Pharmaceuticals was a new HRT Financial position in Q1 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3443 holding.
  • HRT Financial first reported a position in Citius Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
  • HRT Financial's Citius Pharmaceuticals position peaked at $139K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.